MICRONICS JAPAN (6871) FY2026 Q1 Earnings Report

Quick View

Executive Summary

Revenue and earnings increased, primarily driven by expanding demand for the Probe Card Business, demonstrating strong operating leverage, with the growth in operating income significantly exceeding revenue growth. Revenue was ¥209.4B (+48.3% YoY), operating income was ¥56.5B (+97.6%), ordinary income was ¥59.9B (+106.4%), and net income was ¥43.9B (+162.5%). The high growth rate in net income includes ¥10.0B in subsidy income recorded as extraordinary income; therefore, recurring earnings power needs to be assessed based on the growth in operating income and ordinary income.

Factors Affecting Business Performance

【Revenue】Revenue was ¥209.4B, representing a +48.3% YoY increase. The core Probe Card Business generated ¥206.3B (+51.0%) and accounted for 98.5% of consolidated revenue, driving growth. Meanwhile, the Test Equipment Business continued to contract, generating ¥3.2B (-31.3%).

【Profit and Loss】Operating income was ¥56.5B (+97.6%), and the operating margin expanded to 27.0% from 20.2% in the same period of the previous year. Fixed-cost absorption progressed due to a decline in the cost-of-sales ratio and restraint in SG&A expenses (20.3% of revenue), resulting in earnings growth exceeding the rate of revenue growth. Ordinary income was ¥59.9B (+106.4%), also benefiting from ¥3.2B in foreign exchange gains. Net income reached ¥43.9B (+162.5%), including extraordinary income (¥10.0B in subsidy income). Overall, revenue and earnings increased, led by improved profitability at the operating level.

Segment Analysis

The Probe Card Business is the core contributor to consolidated earnings, with revenue of ¥206.3B (+51.0% YoY), segment income of ¥68.2B (+85.4%), and a margin of 33.0% (+610bp from 26.9% in the same period of the previous year). The Test Equipment Business generated revenue of ¥3.2B (-31.3%) and recorded a segment loss of ¥3.1B, with the deficit expanding from the ¥0.96B loss in the same period of the previous year. Corporate expenses were ¥8.6B (+18.8% from ¥7.2B in the same period of the previous year), but the earnings growth of the Probe Card Business absorbed these expenses, resulting in consolidated operating income of ¥56.5B.

Key Financial Indicators

【Profitability】The operating margin of 27.0%, ordinary income margin of 28.6%, and net profit margin of 21.0% all improved substantially from the same period of the previous year (20.2%, 20.5%, and 11.8%, respectively). The gross profit margin remained high at 47.3%.【Cash Quality】Cash and deposits were ¥151.4B, while accounts receivable were ¥138.3B, placing annualized DSO at approximately 60 days. Inventory totaled ¥142.0B, comprising ¥39.8B in raw materials, ¥91.2B in work-in-process, and ¥11.0B in finished goods. Work-in-process accounted for 64.3% of inventory, indicating the degree of funds tied up in the production process.【Investment Efficiency】ROE was 5.9% (based on quarterly results), and excluding ¥10.0B in subsidy income from profit before tax, the amount was ¥59.8B, indicating that recurring earnings were somewhat more modest.【Financial Soundness】The equity ratio was 65.2%, the current ratio was approximately 172%, and net assets of ¥739.9B substantially exceeded interest-bearing debt of ¥64.2B, indicating a solid financial foundation.

Cash Flow Analysis

As cash flow statement data has not been disclosed, fund movements are analyzed based on changes in the balance sheet. Cash and deposits were ¥151.4B, down from ¥193.1B in the previous year, while the accumulation of working capital, including accounts receivable of ¥138.3B and work-in-process of ¥91.2B, appears to have contributed to funds being tied up. The combined amount of accounts receivable and inventory was ¥280.3B, exceeding accounts payable of ¥92.8B by ¥187.6B, indicating substantial working capital requirements during the revenue growth phase. Property, plant and equipment was ¥413.0B, up from ¥387.4B in the previous year, suggesting that investment to expand production capacity is continuing. Interest-bearing debt remained limited at ¥64.2B, and together with the asset composition including investment securities of ¥216.9B, funding capacity is supported by shareholders’ equity.

Earnings Quality

Current-period earnings contain a mix of recurring and non-recurring factors. Of ordinary income of ¥59.9B, the primary driver of non-operating income was ¥3.2B in foreign exchange gains, which are susceptible to market fluctuations. In addition, ¥10.0B in subsidy income was recorded as extraordinary income, equivalent to 22.8% of quarterly net income of ¥43.9B. Profit before tax excluding subsidy income was ¥59.8B, resulting in a discrepancy from the reported profit before tax of ¥69.8B. Comprehensive income was ¥116.2B, exceeding net income by ¥72.2B, primarily due to ¥75.8B in valuation differences on other securities. This discrepancy resulted from changes in the market value of investment securities held, which totaled ¥216.9B, and needs to be distinguished from recurring earnings power generated by business activities.

Earnings Forecasts and Guidance

The full-year company plan calls for revenue of ¥457.0B, operating income of ¥129.0B, and ordinary income of ¥127.0B. Q1 progress rates were 45.8% for revenue, 43.8% for operating income, and 47.2% for ordinary income, substantially exceeding the standard 25% level. However, the operating margin under the full-year plan is 28.2%, slightly above the Q1 actual result of 27.0%; therefore, maintaining high profitability during the remaining period is a prerequisite for achieving the plan. Revenue of ¥247.6B and operating income of ¥72.5B are required from Q2 onward.

Shareholder Returns

The dividend for Q1 was ¥0 per share, and the forecast for the year-end dividend for the fiscal year ending December 2026 is scheduled to be disclosed when the Q2 financial results are announced. Retained earnings were ¥466.6B, cash and deposits were ¥151.4B, and shareholders’ equity was ¥739.9B, indicating a solid financial foundation for dividend funding. The payout ratio has not been calculated at this time, and future disclosures will be closely monitored.

Risk Factors

1. Business concentration risk: Since the Probe Card Business accounts for 98.5% of consolidated revenue, fluctuations in semiconductor capital investment trends have a structure through which they directly affect business performance.

2. Rising quality assurance costs: The provision for product warranties was ¥12.9B, reaching 6.2% of revenue. If quality defects or declining yields occur, this could result in additional costs or lost order opportunities.

3. Working capital retention: Annualized DSO is approximately 60 days, DIO is approximately 117 days, and the work-in-process ratio is high at 64.3%. The retention of inventory and receivables during a period of rapid expansion could delay cash conversion.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The company’s profitability significantly exceeds the manufacturing industry median and is at an outstanding level within the industry.

Growth and Capital Efficiency

The revenue growth rate also significantly exceeds the manufacturing industry median, representing top-tier growth within the industry.

※Source: Compiled by the Company

Key Takeaways from the Financial Results

1. The operating margin of 27.0% and net profit margin of 21.0% are substantially above the manufacturing industry median, with the high profitability of the Probe Card Business driving consolidated performance.

2. The 162.5% growth rate in net income includes the non-recurring factor of ¥10.0B in subsidy income. For evaluating recurring earnings power, it is useful to also review the growth in operating income and ordinary income.

3. Annualized DSO of approximately 60 days, DIO of approximately 117 days, and a work-in-process ratio of 64.3% indicate the degree of working capital retention. The progress of the cash conversion process during the high-growth phase will be a key area to monitor going forward.

Theoretical Share Price (Reference Value)

Sensitivity: ¥2,068–¥2,190 at ±1% for the cost of equity, and ¥2,123–¥2,136 at ±0.1 for ω.

Notes:

• Since net income progress against the full-year forecast (48%) exceeds the standard level (25%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies whose progress is ahead of schedule tend to exceed forecasts. For businesses with strong seasonality, the adjustment may be excessive).
• Net assets as of the end of the quarter are used (there is a time-period discrepancy with the full-year forecast).
• Since net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual income model (Ohlson type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed financial results. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q1 was a very strong earnings quarter for Japan Micronics, led by sharp probe card demand growth and substantial operating leverage. Revenue increased 48.3% year on year to ¥20.95bn. Operating income nearly doubled, rising 97.6% to ¥5.65bn. Ordinary income increased 106.4% to ¥5.99bn. Net income rose 162.5% to ¥4.39bn, exceeding the operating-profit growth rate because of a ¥1.00bn extraordinary subsidy. The operating margin expanded 673bp year on year to 27.0% from 20.2%. Gross margin declined 665bp to 47.3%, indicating that the improvement in operating profitability was driven principally by SG&A leverage rather than a higher gross margin. SG&A expenses declined 10.6% year on year despite the 48.3% sales increase, reducing the SG&A-to-sales ratio by 1,338bp to 20.3%. The Probe Card business was the core earnings engine, with sales up 51.0% to ¥20.63bn and segment profit up 85.4% to ¥6.82bn. Conversely, the TE business remained loss-making, with its segment loss widening to ¥0.31bn from ¥0.10bn despite a 31.3% decline in sales. Q1 revenue already represents 45.8% of the revised full-year sales forecast, while operating income represents 43.8% of the full-year operating-income forecast. This is materially above the standard 25% first-quarter run rate, reflecting both favorable semiconductor test-related demand and the quarterly concentration inherent in the business. Net income quality is partly reduced by the extraordinary subsidy, which represented 22.8% of reported Q1 net income. Foreign-exchange gains of ¥0.32bn also supported ordinary income, though their scale was modest relative to operating income. Liquidity is sound, with a 171.6% current ratio, minimal short-term debt, and cash equal to 52.4 times short-term borrowings. The principal operating risks visible in the quarter are elevated receivable days, high inventory days, an unusually high work-in-process mix, and a warranty provision equivalent to 6.2% of quarterly revenue. The investment case will therefore depend on whether the exceptionally strong probe-card demand can continue while inventory conversion, customer collections, TE profitability, and product-quality costs improve.

Profitability Analysis

The reported annualized DuPont ROE is 23.8%, comprising a 21.0% net profit margin, 0.738x annualized asset turnover, and 1.53x financial leverage. The strongest contributor to the high annualized ROE is the exceptionally high net margin, while the balance sheet is not aggressively levered. The largest year-on-year improvement was operating profitability: the operating margin rose to 27.0% from 20.2%, supported by sales growth materially outpacing SG&A. Gross margin, however, fell to 47.3% from 53.9%, a 665bp contraction, suggesting unfavorable product mix, manufacturing-cost absorption effects, or pricing/mix pressure below gross profit. The operating-margin expansion of 673bp was enabled by SG&A falling to ¥4.25bn from ¥4.76bn, while sales rose ¥6.82bn. This reduced SG&A as a percentage of sales to 20.3% from 33.7%, an improvement that may not recur at the same magnitude once administrative, development, and selling costs normalize. The Probe Card business generated a 33.0% segment margin, up from 26.9%, and is clearly the core business by both sales and segment-profit contribution. The TE business recorded a negative 98.1% segment margin, compared with negative 20.9% in the prior-year quarter, and diluted consolidated profitability. The five-factor analysis shows a 62.9% tax burden, reflecting a 37.1% effective tax rate, while the interest burden exceeded 1.0x because profit before tax benefited from non-operating and extraordinary income. Interest coverage of 332.2x confirms that financing cost is immaterial to current profitability. Reported net income includes the ¥1.00bn subsidy; excluding the ¥0.06bn extraordinary loss, pre-tax profit would have been approximately ¥5.99bn before extraordinary items, so headline net-margin expansion should not be treated as entirely recurring. The 23.8% annualized ROE is excellent against the 15% benchmark, but its sustainability depends on maintaining Probe Card volume, restoring gross-margin momentum, and limiting the losses in TE.

Growth Assessment

Growth was concentrated in the Probe Card business, where sales increased ¥6.97bn year on year to ¥20.63bn. Probe Card segment profit increased ¥3.14bn to ¥6.82bn, demonstrating substantial fixed-cost absorption at higher volumes. TE sales fell from ¥0.46bn to ¥0.32bn and its loss widened by ¥0.21bn, making a turnaround in this business important for consolidated earnings resilience. The company forecasts FY2026 revenue of ¥45.70bn, up 38.0% year on year, and operating income of ¥12.90bn, up 70.4%. Q1 progress is 45.8% for revenue, 43.8% for operating income, 47.2% for ordinary income, and 47.7% for net income, each well above the standard 25% Q1 benchmark. Revenue progress is therefore 20.8 percentage points above a standard quarterly pace and operating-income progress is 18.8 percentage points above it. The revised forecast implies management recognizes a substantially improved demand environment, but it also leaves a lower implied quarterly run rate for the remaining nine months than Q1 achieved. The full-year forecast implies an operating margin of 28.2%, moderately above the Q1 margin of 27.0%, requiring continued SG&A discipline and at least stable gross-margin conditions. The full-year net-income forecast of ¥9.20bn implies Q1 already delivered 47.7% of the target, although Q1 included a non-recurring subsidy. Foreign-exchange gains of ¥0.32bn provided an additional lift to ordinary income and create some sensitivity to exchange-rate movements. Revenue sustainability is closely tied to semiconductor capital-investment cycles, advanced-device test intensity, customer production plans, and competitive positioning in probe cards. The elevated work-in-process balance also indicates that execution through production and delivery will be important to converting demand into future revenue and cash realization.

Financial Health

Financial health is strong. Current assets of ¥45.51bn exceeded current liabilities of ¥26.52bn, producing working capital of ¥18.99bn and a current ratio of 171.6%. The quick ratio was also 171.6%, indicating that stated near-term liquidity is not dependent on inventory liquidation. Cash and deposits were ¥15.14bn, equivalent to 52.4 times short-term loans of ¥0.29bn. Interest-bearing debt totaled ¥6.42bn, comprising ¥0.29bn of short-term loans and ¥6.13bn of long-term loans; therefore, there is no material short-term debt maturity mismatch. Interest-bearing debt represented approximately 8.7% of total equity, while debt/capital was 8.0%, indicating conservative debt funding. The reported debt-to-equity ratio of 0.53x remains below the 1.0x conservative benchmark, and leverage does not constrain operating flexibility. Total equity increased ¥7.93bn year on year to ¥73.99bn, supported by retained earnings and valuation/translation adjustments. Investment securities more than doubled, increasing ¥11.04bn, or 103.6%, to ¥21.70bn and reaching 19.1% of total assets. This increase was accompanied by a ¥7.58bn positive valuation difference on securities in OCI, making a meaningful portion of equity sensitive to market-value fluctuations in the securities portfolio. Cash declined ¥4.16bn year on year to ¥15.14bn, but the resulting liquidity position remains ample. Long-term loans rose ¥0.27bn year on year to ¥6.13bn, a limited movement relative to the capital base. Provision for bonuses increased to ¥3.63bn from ¥2.27bn, consistent with improved earnings and compensation accruals but also increasing current-liability requirements. Product-warranty provision declined to ¥1.29bn from ¥1.61bn, although the remaining balance is still high relative to quarterly sales. No balance-sheet leverage warning is triggered: the current ratio is well above 1.0x and D/E is well below 2.0x.

Notable B/S Changes

Investment securities: +¥11.04bn (+103.6%) to ¥21.70bn - the portfolio now represents 19.1% of total assets; unrealized valuation movements are a meaningful source of OCI and equity volatility. Cash and deposits: -¥4.16bn (-21.6%) to ¥15.14bn - liquidity remains strong, but the decline should be assessed alongside inventory, receivable, and investment-security movements. Total liabilities: +¥6.50bn (+19.7%) to ¥39.47bn - the increase remains manageable against ¥73.99bn of equity and does not create a leverage concern. Noncurrent liabilities: +¥3.21bn (+33.0%) to ¥12.95bn - mainly relevant for monitoring the evolution of long-term obligations, although long-term loans rose only modestly to ¥6.13bn. Provision for bonuses: +¥1.37bn (+60.3%) to ¥3.63bn - consistent with improved earnings and compensation accruals, but it increases near-term operating-liability requirements.

Cash Flow Quality

Working-capital indicators warrant close monitoring. Annualized receivable days are flagged above 60 days, exceeding the manufacturing efficiency benchmark of below 45 days. Receivables increased ¥2.42bn year on year to ¥13.83bn, broadly reflecting higher sales but requiring prompt cash collection as quarterly shipment volumes expand. Annualized inventory days are 117 days, well above the 90-day warning threshold. Inventory totaled ¥14.20bn, comprising raw materials of ¥3.98bn, work in process of ¥9.13bn, and finished goods of ¥1.10bn. Work in process represented 64.3% of total inventory, above the 40% warning threshold and indicative of a potentially extended production cycle, capacity bottleneck, product-complexity effect, or deliveries awaiting completion. The high work-in-process ratio is especially relevant for a semiconductor-test equipment supplier because demand peaks can require significant production staging, but it raises the risk of delayed conversion into customer acceptance and cash receipts. Raw materials were broadly stable year on year, while work in process increased ¥0.88bn and finished goods increased ¥0.18bn. Accounts payable increased ¥1.78bn to ¥9.28bn, providing some supplier financing against inventory and production growth. Nevertheless, the combination of elevated DSO and DIO points to a potentially extended cash conversion cycle and should be monitored for evidence of inventory accumulation rather than normal order fulfillment. The warranty provision of ¥1.29bn equals 6.2% of Q1 revenue, substantially above the 3% warning benchmark. The root cause of this warning is that warranty-related obligations are large relative to current sales, potentially signaling elevated field-support, repair, qualification, or product-performance costs. For semiconductor test hardware, warranty and reliability exposure can be more pronounced during technology transitions and customer ramp-ups; however, the ratio remains high even after the provision declined from the prior year. The impact is a potential drag on future gross margin and an increased risk that customer-quality issues could delay acceptance, increase service costs, or constrain new orders.

Dividend Sustainability

No Q1 dividend was paid, which is consistent with a year-end distribution structure rather than evidence of weak financial capacity. The company plans to disclose its FY2026 year-end dividend forecast with the second-quarter earnings release. Q1 EPS was ¥113.32, while full-year EPS is forecast at ¥237.33. The absence of a stated full-year DPS prevents calculation of a dividend payout ratio. Balance-sheet capacity is sound, with ¥15.14bn of cash, low interest-bearing debt of ¥6.42bn, a 171.6% current ratio, and annualized ROE of 23.8%. Retained earnings of ¥46.66bn also provide a substantial equity buffer. Dividend capacity will depend primarily on the durability of Probe Card earnings, the cash conversion of receivables and inventory, capital-investment requirements, and the scale of warranty-related cash costs. The Q1 subsidy boosted reported earnings but should not be assumed to support recurring shareholder distributions. Any eventual payout assessment should distinguish dividends from other capital returns; a total return ratio would be appropriate only if share repurchases are announced.

Risk Assessment

Business risks include Semiconductor-cycle risk: the 51.0% sales growth in Probe Cards reflects strong demand but exposes earnings to changes in memory, logic, advanced packaging, and customer capital-expenditure cycles., Customer concentration and qualification risk: probe cards are technically demanding products, and order timing, customer acceptance, qualification delays, or design changes can affect quarterly sales and work-in-process conversion., TE business risk: TE revenue declined 31.3% year on year and its segment loss widened to ¥0.31bn, increasing the need for either a recovery in scale or tighter cost control., Production-execution risk: work in process accounts for 64.3% of inventory, suggesting elevated exposure to manufacturing bottlenecks, delivery timing, and production-completion risk., Product-quality risk: warranty provision is 6.2% of revenue, above the 3% warning level; this may lead to repair, replacement, customer-support, and reputation costs., Foreign-exchange risk: Q1 included ¥0.32bn of FX gains, so ordinary earnings retain some currency sensitivity..

Financial risks include Working-capital risk: annualized DSO above 60 days and annualized DIO of 117 days may delay cash conversion if customer collections or production throughput weaken., Securities-market risk: investment securities of ¥21.70bn equal 19.1% of assets, and sizeable unrealized gains contribute to OCI and equity sensitivity., Earnings-normalization risk: the ¥1.00bn extraordinary subsidy represented 22.8% of Q1 net income and should not be extrapolated as recurring profit., Tax-rate risk: the 37.1% effective tax rate reduced the tax burden to 62.9%, below the normal-tax-burden benchmark of 70%..

Key concerns include Highest priority: sustain Probe Card demand and gross-margin performance after a quarter in which gross margin declined 665bp despite strong operating leverage., High priority: improve inventory conversion and receivable collection, as the combination of high DSO, 117 inventory days, and high WIP can pressure cash generation., High priority: reduce the warranty burden and demonstrate that the provision reflects routine support needs rather than persistent product-quality issues., Medium priority: narrow TE losses to reduce earnings volatility and improve group resource allocation., Medium priority: monitor changes in the securities portfolio because fair-value movements can materially affect comprehensive income and equity..

Investment Implications

Key takeaways include Q1 demonstrated strong operating leverage: revenue rose 48.3% while operating income rose 97.6%, lifting the operating margin to 27.0%., Probe Cards are the clear core business, contributing ¥20.63bn of sales and ¥6.82bn of segment profit, while TE remains structurally dilutive in Q1., Q1 progress against the revised annual plan is unusually high, at 45.8% for sales and 43.8% for operating income, supporting the revised outlook but raising the importance of quarterly demand normalization., Balance-sheet liquidity and debt service capacity are strong, with low short-term debt and 332.2x interest coverage., The main counterweights to strong profitability are non-recurring subsidy income, lower gross margin, elevated working capital, and the high warranty ratio..

Metrics to watch include Probe Card sales growth, segment margin, and order/delivery cadence, Consolidated gross margin versus the Q1 level of 47.3%, TE segment revenue and operating loss, Annualized DSO above 60 days, annualized DIO of 117 days, and the work-in-process share of inventory, Warranty provision relative to revenue and evidence of field-quality improvement, Progress against FY2026 forecasts: revenue ¥45.70bn, operating income ¥12.90bn, ordinary income ¥12.70bn, and net income ¥9.20bn, FX gains/losses and fair-value movements in the ¥21.70bn investment-securities portfolio, Year-end dividend policy to be disclosed at the Q2 results announcement.

Regarding relative positioning, Japan Micronics displays profitability and annualized ROE that are well above the stated excellence thresholds for manufacturing companies, supported by a high-margin Probe Card franchise and modest financial leverage. Relative positioning is tempered by a lower gross margin, a loss-making TE segment, high production-stage inventory, elevated receivable days, and a warranty ratio that is materially above normal manufacturing benchmarks.